logo

For the Inventor, By the Inventor

North Brunswick, NJ, United States of America

Pds Biotechnology Corporation


USPTO Granted Patents = 14


Trademarks = 4

Forward Citations = 186

Loading Chart...
Loading Chart...

22 inventors (with patents filed for the assignee):

goldMedal Frank Bedu-Addo (13 out of 14 patents)

silverMedal Leaf Huang (6 out of 42 patents)

bronzeMedal Kenya Johnson (6 out of 6 patents)

4.  Eric Jacobson (5 out of 8 patents)

5.  Gregory Conn (4 out of 4 patents)

6.  Martin Ward (3 out of 4 patents)

7.  Jerold Woodward (3 out of 5 patents)

8.  Samir N Khleif (3 out of 24 patents)

9.  Mikayel Mkrtichyan (3 out of 18 patents)

10.  Elizabeth Ann Vasievich (3 out of 3 patents)

11.  Kenya N Toney Johnson (3 out of 3 patents)

12.  Weihsu Claire Chen (3 out of 3 patents)

13.  Greg Conn (2 out of 3 patents)

14.  Weihsu Chen (2 out of 4 patents)

15.  Weili Yan (2 out of 2 patents)


14 patents:

1. 12551460 - METHODS AND COMPOSITIONS COMPRISING CATIONIC LIPIDS FOR STIMULATING TYPE 1 INTERFERON GENES (2026-02-17),
2. 12201685 - Methods of modulating immune responses with cationic lipid vaccine compositions (2025-01-21),
3. 11911465 - Vaccine compositions and methods of use (2024-02-27),
4. 11911359 - Stimulation of an immune response by cationic lipids (2024-02-27),
5. 11904015 - Vaccine compositions and methods of use (2024-02-20),
6. 11801257 - Stimulation of an immune response by enantiomers of cationic lipids (2023-10-31),
7. 11612652 - Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy (2023-03-28),
8. 11401306 - HPV16 non HLA-restricted t-cell vaccines, compositions and methods of use thereof (2022-08-02),
9. 10828364 - Method for reducing a myeloid derived suppressor cell population with cationic lipid vaccine compositions (2020-11-10),
10. 10702541 - Stimulation of an immune response by enantiomers of cationic lipids (2020-07-07),
11. 10286064 - Cationic lipid vaccine compositions and methods of use (2019-05-14),
12. 9789129 - Stimulation of an immune response by enantiomers of cationic lipids (2017-10-17),
13. 8877206 - Stimulation of an immune response by cationic lipids (2014-11-04),
14. 7303881 - Antigen delivery compositions and methods of use (2007-12-04),
Pds Biotechnology Corporation is a clinical-stage immunotherapy company focusing on the development of novel therapies for cancer and infectious diseases. Their platform technology, Versamune, is designed to enhance the body's immune response to target and destroy cancer cells. The company is dedicated to advancing innovative treatments that have the potential to improve patient outcomes and quality of life.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Pds Biotechnology Corporation
14 Patents

#5 in North Brunswick, NJ

#839 in New Jersey

#22,289 in US

#42,168 in the World

North Brunswick, NJ (US)
North Brunswick, NJ, United States of America

Pds Biotechnology Corporation

Forward Citations = 186

22 inventors:

goldMedal Frank Bedu-Addo (13 out of 14 patents)

silverMedal Leaf Huang (6 out of 42 patents)

bronzeMedal Kenya Johnson (6 out of 6 patents)

4.  Eric Jacobson (5 out of 8 patents)

5.  Gregory Conn (4 out of 4 patents)

Please report any incorrect information to [email protected]
Loading…